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Abstract 
Background: The available methods to assess left atrial function (LAF) have some 
limitations as angle dependence and opposite distortion. The objective of the 
current study was to evaluate LAF in dilated cardiomyopathy (DCM) of ischemic 
(IDCM) and non-ischemic etiologies (NIDCM) using speckle tracking 
echocardiography (STE). 
Methods: 52 patients with systolic heart failure were included in our study; 27 with 
IDCM and 25 with NIDCM along with 15 healthy controls. All patients underwent 
conventional echocardiography, tissue doppler imaging, and speckle tracking 
echocardiography. The later modality was used to compare left atrial function in 
IDCM and NIDCM groups.  
Results: We found the left atrial maximum volume and the left atrial total emptying 
volume to be higher in patients with dilated cardiomyopathy compared to healthy 
patients (52.19 ± 6.01 vs.  21.87 ± 1.69 cm3/m2; p <0.001 and 28.67 ± 4.34 vs. 15.67 
± 2.02 cm3/m2, respectively). Conversely, left atrial emptying index and left atrial 
active ejection fraction were lower in patients with DCM compared to healthy 
controls (9.60 ± 2.29 vs. 8.27 ± 3.01 cm3/m2; p< 0.001 and 23 ± 2.56 vs. 37.47 ± 3.54 
%; p<0.001, respectively). When comparing the IDCM group with NIDCM patients, 
we found no significant difference in left atrial maximum volume and left atrial 
active emptying volume. However, the NIDCM patients had significantly lower left 
atrial total emptying volume, and left atrial active ejection fraction (8.93 ± 1.86 vs. 
9.60 ± 2.29 cm3/m2 and 23 ± 2.56 vs. 31.19 ± 1.66 %; p<0.001). on comparing strain 
function, DCM patients had lower systolic (28.22 ± 3.84 vs. 60.87 ± 3.07 %, p<0.001), 
and left atrial systolic strain rate (-2.66 ± 0.45 vs. -3.81 ± 0.35; p = 0.003) compared 
to healthy controls. All strains and strain rates were signiﬁcantly lower in NIDCM 
patients compared to IDCM patients. 
Conclusion: STE is a promising method for evaluating LAF in DCM patients. Patients 
with DCM had significantly lower left atrial systolic and late diastolic strains and 
strain rates compared to healthy patients. Moreover, NIDCM could be 
differentiated from IDCM by having more impairment in the LA dynamic reservoir 
and booster pump function. 
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Introduction 
Dilated Cardiomyopathy (DCM) is a 
progressive cardiac muscle disease characterized 
by enlargement of the ventricular chambers with 
contractile and filling dysfunction [1]. The major 
cause of DCM is ischemic heart disease; more than 
60% of DCM cases are due to ischemia, which is 
responsible for ventricular dilatation [2]. On the 
other hand, non-ischemic DCM (NIDCM) usually 
develops with different diseases, such as 
Takotsubo cardiomyopathy, familial NIDCM, and 
myocarditis [3-5]. Left ventricular (LV) diastolic 
dysfunction (as in DCM) interrupts the left atrium 
(LA) reservoir function as it increases the LV filling 
pressure (LVFP), which increases LA pressure, 
causing chamber dilatation [6-8]. Subsequently, 
LA remodeling occurs, which interferes with the 
microcirculation of the atrium and subsequent 
chronic ischemia, ﬁbrosis, and left atrial 
dysfunction [9].  
The LA volumetric parameters and myocardial 
deformation by tissue Doppler imaging (TDI) have 
been used to describe the effect of LVFP on the LA. 
Previous authors have shown by standard 
echocardiography that the LA bump booster 
function is more impaired in NIDCM compared to 
IDCM [10, 11]. However, TDI faced some critique 
because its measurements are angle-dependent 
due to Doppler effects and opposite distortion in 
the long and short axes [12, 13]. Recently, 2D 
speckle-tracking echocardiography (2D-STE) has 
shown promise as a new echocardiographic 
approach that analyzes motion based on tracking 
speckle patterns on B-mode images of the US 
beams in the myocardium [14]. 
In contrast to TDI, 2D-STE has the ability to 
measure myocardial strain independent of the 
angle of insonation during each cardiac cycle and 
also quantify LV function [15, 16]. Although the 
2D-STE technique was introduced for the exclusive 
analysis of LV, it has recently been developed to 
qualify longitudinal myocardial LA deformation 
dynamics [17]. In this study, we aimed to assess 
LA function in DCM patients of ischemic and non-
ischemic etiologies using STE. 
Patients and Methods: 
Study Design:  
The study included 67 randomly selected 
individuals who presented first to the Cardiac 
Surgery Clinic and were deemed not demanding 
surgery, then referred to Al-Azhar Islamic Center 
of Cardiology, Egypt, between January 2017 and 
October 2017. We included 52 patients with 
systolic HF, EF less than 50%, and the New York 
Heart Association (NHYA) ranging from class II to 
IV (patient group) and 15 healthy individuals 
(control group). Our patients included 27 patients 
with IDCM (IDCM group) and 25 patients with 
NIDCM.  We obtained informed consent from all 
patients, and the study had the approval of Al-
Azhar University Institutional Research Board. 
Inclusion and Exclusion criteria: 
We included patients with systolic HF (NYHA 
class II to IV) because of IDCM or INIDCM. We 
excluded patients with any rhythm abnormality, 
significant valvular lesions, congenital heart 
disease, recent acute coronary syndrome, poor 
echogenic window, and renal or liver cell failure. 
IDCM patients had an old myocardial infarction 
incident. NIDCM patients met 1996 WHO 
diagnostic criteria. 
Echocardiography Study: 
Transthoracic echocardiography was 
performed using a GE Vivid E9 ultrasonographic 
unit and an M5S probe (frequency 1.7–3.3 MHz). 
ECG was simultaneously recorded. Then, we 
employed the following modes to capture 
echocardiographic data: 
M-Mode: Left atrial diameter (LAD), left 
ventricular end-diastolic diameter (LVEDd), 
interventricular septal wall thickness (IVSd), and 
LV posterior wall (LVPW), and left fractional 
ventricular shortening (FS) and ejection fraction 
(EF). 
Doppler study: Pulsed wave doppler 
echocardiography was performed on the mitral 
valve. We measured the trans-mitral doppler flow 
velocity and recorded peak early filling velocity (E), 
peak atrial velocity (A), and the deceleration time 
(DT) of the E wave. We then calculated the E/A 
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Table 1: Clinical and basic echocardiographic data in the studied groups. A value of p < 0.05 was considered statistically 
signiﬁcant. 
Parameters Control NIDCM IDCM P 
Age years (Mean ± SD) 52.87 ± 2.99 51.36 ± 9.45 56.81 ± 3.77 0.064 
Sex Male  10 (66.6) 15 (60) 19 (70.4) 0.740 
HR b/m (Mean ± SD) 68.87 ± 4.27 72.16 ± 10.32 76.52 ± 5.48 0.007 
Current smoking 5 (33.3) 10 (40) 10 (37.03) 0.918 
DM 5 (33.3) 12 (48) 16 (59.3) 0.279 
Systolic BP mmHg 128 ± 18.3 120.2 ± 17.47 120.37 ± 20.6 0.388 
Diastolic BP mmHg 75 ± 11.8 72.2 ± 11.82 72.78 ± 9.93 0.732 
Dyslipidemia 7 (46.7) 11 (44) 19 (70.4) 0.125 
E (cm/s) 69.73 ± 6.71 63.96 ± 8.75 64.81 ± 9.44 0.111 
A (cm/s) 45.53 ± 8.63 35.00 ± 6.25 32.63 ± 3.86 <0.001 
E/A 1.55 ± 0.16 1.844 ± 0.37 1.98 ± 0.24 <0.001 
DT (ms) 188.33 ± 6.94 160.96 ± 17.04 155.59 ± 15.32 <0.001 
Septal e´ (cm/s) 7.84 ± 0.54 4.41 ± 0.67 4.34 ± 0.73 <0.001 
E/e´ 8.73 ± 0.80 14.68 ± 3.39 15.11 ± 3.21 <0.001 
LAD (cm) 3.43 ± 0.24 4.67 ± 0.50 4.77 ± 0.46 <0.001 
LVEDd (cm) 4.55 ± 0.18 6.276 ± 0.55 6.28 ± 0.62 <0.001 
FS (%) 30.47 ± 1.81 16.44 ± 2.16 14.48 ± 1.86 <0.001 
LVEF (%) 60.87 ± 3.07 32.60 ± 4.48 28.22 ± 3.84 <0.001 
LAVmax (cm3/m2) 21.87 ± 1.69 48.84 ± 8.24 52.19 ± 6.01 <0.001 
LATV (cm3/m2) 15.67 ± 2.02 17.32 ± 4.785 28.67 ± 4.34 <0.001 
LAEV (cm3/m2) 8.27 ± 3.01 9.60 ± 2.29 8.93 ± 1.86 0.210 
AEI (%) 94.80 ± 10.93 45.28 ± 9.11 54.93 ± 7.97 <0.001 
LAAEF (%) 37.47 ± 3.54 23 ± 2.56 31.19 ± 1.66 <0.001 
NIDCM: idiopathic dilated cardiomyopathy; IDCM: ischemic dilated cardiomyopathy; HR: heart rate; 
DM: diabetes mellitus; BP: blood pressure; E: blood ﬂow velocity of mitral valve at early diastolic; A: 
blood ﬂow velocity of mitral valve at late diastole; DT,: deceleration time of E peak; e’: velocity of the 
initial wave of the septal mitral annulus; LAD: left atrial anteroposterior diameter; LVEDD: left 
ventricular end-diastolic diameter; FS: fractional shortening; LVEF: left ventricular ejection fraction; 
LAVmax: left atrial maximum volume; LATV: left atrial total emptying volume; LAEV: left atrial active 
emptying volume; AEI: left atrial expansion index; LAAEF: left atrial active ejection fraction 
ratio. We used two-dimensional 
echocardiography to measure LA volumes at the 
end of systole (Max AV), diastole (Min AV), and 
preceding atrial contraction (VPre-A). 
Tissue Doppler imaging: We measured the 
velocity of the septal mitral annulus at early 
diastole (e’), and the E/e’ ratio to estimate the 
filling pressures of the LV. 
2D speckle tracking echocardiography: We 
measured the LA strain (Ss), systolic strain rate 
(SRs), and late diastolic strain (Sa). For the left 
ventricle, we calculated the average of the 
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longitudinal systolic strain of all segments to 
obtain a 2D global longitudinal strain (GLS) value. 
Statistical Analysis 
We performed statistical analysis using the 
SPSS software (version 22 for Windows, IBM Inc, 
Armonk, NY).  We employed the ANOVA test to 
analyze the difference between the three included 
groups. To compare two groups (for example, 
DCM vs. control or IDCM vs. NIDCM), we used the 
t-test. We used the Spearman correlation analysis 
to assess the correlation between atrial function 
and strain parameters. A p-value of < 0.05 was 
considered statistically significant.   
Results 
Baseline Data: We recorded no significant 
differences between the DCM and control groups 
in terms of age (p = 0.06), gender (p = 0.47), 
frequency of smoking (p = 0.9), diabetes mellitus 
(p = 0.27), dyslipidemia (p = 0.12) and 
systolic/diastolic blood pressure levels (p = 0.38 
and 0.73) (Table 1).  
Basic echocardiographic parameters: The A peak, 
DT, septal e’, FS% and LVEF% were lower in the 
NIDCM and IDCM groups than in the control 
group, while the E/A, E/e’ and LAD, and LVEDd 
were higher in the NIDCM and IDCM groups than 
in the control group (p < 0.001). However, there 
were no signiﬁcant differences between the 
NIDCM and IDCM groups in the A peak, DT, septal 
e’, E/A, E/e’ and LAD, LVEDd. However, the FS% 
and LVEF % were lower in the IDCM than the 
NIDCM group (p < 0.001) (Table 1). 
Left atrial volume and function indices: The left 
atrial maximum volume (LAV max) and the left 
atrial total emptying volume (LATV) was higher in 
patients with DCM compared to healthy controls 
(p < 0.001). Conversely, left atrial emptying index 
(AEI) and left atrial active ejection fraction (LAAEF) 
were lower in patients with DCM compared to 
healthy controls (p < 0.001). No significant 
difference in LAVmax (p = 0.07) and left atrial 
active emptying volume (LAEV; p = 0.09) was 
found between the IDCM and NIDCM patients. 
However, the NIDCM patients had significantly 
lower left atrial emptying index (AEI), left atrial 
total emptying volume (LATV), and left atrial active 
ejection fraction (LAAEF) (p<0.01) (Table 1). 
Left atrial strain and strain rate: DCM patients had 
lower systolic (LASs), late diastolic (Sa) (p <0.001), 
and left atrial systolic strain rate (SRs) (p = 0.003) 
compared to healthy patients. All strains and 
strain rates were signiﬁcantly lower in NIDCM 
patients compared to IDCM patients (p<0.05) 
(Table 2). 
Correlation between LA strain and function: We 
recorded significant and strong correlations (p < 
0.001) between all tested LAF parameters 
(LAVmax, LATV, AEI, and LAAEF) and all tested 
atrial strain rates (average LA Ss, average LA SRs, 
Average LA Sa, Average LA SRa). Except for 
average LA Sra that had negative correlations with 
all atrial function parameters, other strain rates 
had all positive correlations with LA function 
parameters (Table 3). 
Discussion 
In this study, we found that: all strain 
parameters were lower in DCM patients 
compared to healthy controls, all strain 
parameters were signiﬁcantly lower in NIDCM 
patients compared to IDCM patients, and all strain 
parameters were positively correlated with left 
atrial emptying function and left atrial active 
ejection fraction. 
Comparison of LA strains and strain rates in 
NIDCM patients and controls: Strain and strain 
rate imaging have been introduced recently as an 
important method for LA function evaluation. The 
strain is a term used to describe the degree of 
shortening, thickening, and lengthening of 
contracting myocardial wall. Strain rate is defined 
as the strain per unit time which reflects real-time 
myocardial movement [18]. In the present study, 
strain and strain rate were signiﬁcantly lower in 
DCM patients compared to healthy controls.  
In a previous study, Inaba and coworkers 
showed that SRs, SRe, and SRa could reﬂect the LA 
reservoir, conduit, and booster pump function, 
respectively [19]. Our analysis showed lower Ss, 
Sa, SRs, and Sra in NIDCM and IDCM patients than 
the healthy controls indicating that LA dynamic
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Table 2: Left Atrial (Strain and Strain Rates) and Left ventricular (longitudinal strain and strain rates) in the three studied 
groups. A value of p < 0.05 was considered statistically signiﬁcant. 
Parameters Control IDCM NIDCM P 
LA septal wall Ss (%) 59.07 ± 5.84 38.19 ± 3.08 27.96 ± 5.17 <0.001 
LA Lateral wall Ss (%) 64.67 ± 5.78 40 ± 3.16 28.76 ± 6.89 <0.001 
LA Anterior wall Ss (%) 51.20 ± 5.71 33.19 ± 3.18 22.96 ± 5.94 <0.001 
LA Inferior wall Ss (%) 48.73 ± 5.92 32.96 ± 3.16 21.48 ± 5.19 <0.001 
Average LA Ss (%) 56.03 ± 9.43 35.59 ± 7.02 27.83 ± 5.95 <0.001 
LA Septal wall SRs (s-ˡ) 5.26 ± 0.35 3.33 ± 0.30 3.26 ± 0.43 0.534 
LA Lateral wall SRs (s-ˡ) 6.13 ± 0.36 4.18 ± 0.30 4.06 ± 0.51 0.322 
LA Anterior wall SRs (s-ˡ) 3.59 ±0.36 3.11 ± 0.30 1.72 ± 0.33 <0.001 
LA Inferior wall SRs (s-ˡ) 3.03 ± 0.41 2.60 ± 0.30 1.70 ± 0.21 <0.001 
Average LA SRs (s-ˡ) 4.48 ± 0.97 3.31 ± 0.73 2.77 ± 0.48 0.003 
LA Septal wall Sa (%) 25.60 ± 2.746 16.37 ± 2.43 12.84 ± 4.11 <0.001 
LA Lateral wall Sa (%) 28.40 ± 2.74 20.11 ± 2.44 14.96 ± 4.31 <0.001 
LA Anterior wall Sa (%) 22.80 ± 2.65 15.11 ± 2.62 10.04 ± 4.42 <0.001 
LA Inferior wall Sa (%) 21.20 ± 2.65 11.48 ± 2.36 8.48 ± 3.32 <0.001 
Average LA Sa (%) 24.57 ± 3.24 15.95 ± 4.12 11.67 ± 2.75 <0.001 
LA Septal wall SRa (s-ˡ) -4.62 ± 0.27 -3.28 ± 0.16 -2.77 ± 4.45 <0.001 
LA Lateral wall SRa (s-ˡ) -5.21 ± 0.27 -4.23 ± 0.16 -3.36 ±.46 <0.001 
LA Anterior wall SRa (s-ˡ) -3.57 ± 0.27 -1.49 ± 0.69 -1.77 ± 0.45 0.095 
LA Inferior wall SRa (s-ˡ) -1.85 ± 0.28 -1.41 ± 0.64 -1.61 ± 0.46 0.2 
Average LA SRa (s-ˡ) -3.81 ± 0.35 -2.66 ± 0.45 -2.30 ± 0.57 0.016 
Basal ANT wall LS of LV (%) -21.73 ± 1.486 -13.96 ± 1.85 -9.44 ± 1.58 <0.001 
Basal Anteroseptal wall LS of LV (%) -18.73 ± 1.03 -13.67 ± 2.93 -8.56 ± 1.58 <0.001 
Basal Septal wall LS of LV (%) -19.00 ± 0.84 -13.96 ± 1.85 -9 ± 1.44 <0.001 
Basal INF wall LS of LV (%) -22.80 ± 0.94 -14.81 ± 8.46 -12.52 ± 1.63 0.189 
Basal POST wall LS of LV (%) -21.20 ± 0.94 -14.74 ± 4.18 -10.40 ± 1.53 <0.001 
Basal LAT wall LS of LV (%) -22.07 ± 1.39 -12.37 ± 1.94 -10 ± 1.44 <0.001 
MID ANT wall LS of LV (%) -22.60 ± 0.98 -14.70 ± 4.62 -11.12 ± 1.48 <0.001 
MID Anteroseptal wall LS of LV (%) -21.20 ± 0.94 -13.67 ± 2.93 -11.20 ± 1.50 <0.001 
MID Septal wall LS of LV (%) -21.40 ± 1.24 -14.74 ± 2.74 -10.60 ± 1.53 <0.001 
MID INF wall LS of LV (%) -20.20 ± 11.96 -13.74 ± 6.12 -11.52 ± 1.53 0.084 
MID POST wall LS of LV (%) -20.60 ± 0.98 -12.22 ± 3.70 -8.20 ± 1.50 <0.001 
MID LAT wall LS of LV (%) -21.20 ± 0.94 -11.96 ± 2.75 -10.24 ± 1.45 0.007 
Apical ANT wall LS of LV (%) -23.07 ± 0.59 -10.59 ± 7.30 -11.52 ± 1.53 0.537 
Apical Anteroseptal wall LS of LV (%) -24 ± 0.84 -10.48 ± 6.81 -11.68 ± 1.52 0.394 
Apical INF wall LS of LV (%) -24 ± 0.001 -9.78 ± 2.06 -10.80 ± 1.50 0.048 
Apical LAT wall LS of LV (%) -21.4 ± 0.98 -10.81 ± 5.07 -8.72 ± 1.51 0.053 
GLS 2-chamber view (%) -22.40 ± 0.92 -11.65 ± 4.45 -10.50 ± 1.47 0.222 
GLS 4-chamber view (%) -21.31 ± 0.87 -14.02 ± 1.84 -9.12 ± 4.24 <0.001 
GLS 2-Long-axis view (%) -20.60 ± 0.89 -10.86 ± 0.75 -9.60 ± 4.34 0.142 
Global LS of LV (%) -21.51 ± 0.43 -12.40 ± 1.35 -10.29 ± 1.46 <0.001 
NIDCM: idiopathic dilated cardiomyopathy; IDCM: ischemic dilated cardiomyopathy; LA: left atrium; LV: 
left ventricle; Ss: left atrial systolic strain; SRs: left atrial systolic strain rate; Sa: left atrial late diastolic 
strain; SRa: left atrial late diastolic strain rate; ANT: anterior; INF: inferior; POST: posterior; LAT: lateral; 
LS : longitudinal strain; GLS: global longitudinal strain 
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Table 3: Correlations between LA deformation (LA Strains and Strain Rates) and Left Atrial Volume and Function Indexes 
in NIDCM Patients. (p < 0.05) Correlation is significant. 
Average LA Ss (%) Average LA SRs (s-ˡ) Average LA Sa (%) Average LA SRa (s-ˡ) 
LAVmax 
(cm3/m2) 
r 0.932 0.900 0.929 -0.937 
p <0.001   <0.001 <0.001 <0.001 
LATV 
(cm3/m2)  
r 0.946 0.927 0.950 -0.952 
p <0.001 <0.001 <0.001 <0.001 
AEI (%) 
r 0.974 0.947 0.970 -0.972 
p <0.001 <0.001 <0.001 <0.001 
LAAEF (%) 
r 0.982 0.962 0.980 -0.970 
p <0.001 <0.001 <0.001 <0.001 
LA: left atrium; NIDCM: non-ischemic dilated cardiomyopathy; LAVmax: left atrial maximum volume; 
LATV: left atrial total emptying volume; AEI: left atrial expansion index; LAAEF: left atrial active ejection 
fraction; Ss: left atrial systolic strain; SRs: left atrial systolic strain rate; Sa: left atrial late diastolic strain; 
SRa: left atrial late diastolic strain rate 
reservoir and booster pump functions were 
compromised. Moreover, we found higher E/e’ 
and lower LVEF in DCM patients than healthy 
controls. In agreement, Gulr and colleagues 
showed LA function impairment in patients with 
echocardiographically detected diastolic 
dysfunction [20]. 
Comparison of LA strains and strain rates in 
NIDCM and IDCM patients: We recorded no 
signiﬁcant differences between NIDCM and IDCM 
patients in terms of basic echocardiographic 
variables, including the A peak, deceleration time 
(DT), septal e’, E/A, E/e’, LAD and LVEDD. 
However, left atrial parameters were lower in 
NIDCM than in IDCM patients. This was in 
agreement with Moyssakis and associates (using 
stress echocardiography) [11] and D’Andrea and 
coworkers (using 2DSTI) [21]. Left Atrial dynamic 
reservoir and booster pump functions were 
decreased in NIDCM patients and partially 
preserved in IDCM patients despite similar loading 
conditions and LA sizes. 
It is reasonable to assume that the depressed 
LA function in NIDCM patients is the result of LA 
involvement in the cardiomyopathy process [22]. 
This assumption is supported by previous ﬁndings 
of higher degrees of LA changes in NIDCM than in 
IDCM patients. Moreover, Sen and associates 
identiﬁed lower amplitude of cell motion in 
NIDCM than IDCM patients, as well as significant 
differences in the sarcoplasmic reticulum, Ca 
release dysfunction between NIDCM and IDCM. 
The latter plays a crucial role in abnormal Ca21 
homeostasis in NIDCM patients leading to 
impaired LV systolic and diastolic function over 
time. In such circumstances, LA pressure and size 
would increase, and the AEI and LAAEF would 
decrease [23]. 
Molina-Navarro and associates examined the 
global transcriptome profiles using RNA-
Sequencing and GeneMANIA of 31 LV myocardial 
tissue samples (10 IDCM; 13 NIDCM; 8 control 
donors). The study showed different expression in 
nine and 12 nucleocytoplasmic transport-related 
genes in the IDCM and NIDCM groups. Six altered 
genes showed identical expression trends in both 
diseases: XPO1, ARL4, NFKB2, FHL3, RANBP2, and 
RHOU. However, INIDCM patients showed 
expression of three unique genes (DDX3X, KPNA2, 
and PTK2B), whereas, other sex genes were 
expressed only in NIDCM patients (SMURF2, 
NUP153, IPO5, RANBP3, NOXA1, and RHOJ) [24]. 
Correlation between LA strain rates and LA 
volume index: In our study, the LA strain rate was 
positively correlated with volume indices such as 
AEI and LAAEF. This suggests that it could reﬂect 
LA dysfunction at different points of the cardiac 
cycle. We found that LAVmax was higher in NIDCM 
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and IDCM patients than the control group. 
However, AEI and LAAEF were lower, indicating 
changes in the dynamic reservoir and booster 
pump function. This might be explained by the 
following: impairment of Left ventricular 
contraction and active relaxation, which hinders 
the motion of the mitral valve ring, compensation 
of left ventricular diastolic dysfunction by atrial 
booster pump function. Higher LVFP increased 
left atrial pressure and reduced LAAEF [25]. In 
addition, we found no significant difference in 
LAVmax and LAEV between the NIDCM and IDCM 
groups, but AEI and LAAEF were lower in NIDCM 
patients, albeit having similar Left ventricular 
systolic and diastolic function and Left atrial size. 
Study limitations 
Limitations of Our study includes the small 
sample size and the ability of STI to estimate 
deformation in 3D independently of angle, which 
gives additional information such as the 
longitudinal, circumferential, radial, and area 
strain. 
Conclusion 
STE is a promising method for evaluating LAF in 
DCM patients. Patients with DCM had significantly 
lower left atrial systolic and late diastolic strains 
and strain rates compared to healthy patients. 
Moreover, NIDCM could be differentiated from 
IDCM by having more impairment in the LA 
dynamic reservoir and booster pump function. 
Conflict of interest: Authors declare no conflict of 
interest. 
References 
1. Schultheiss HP, Fairweather D, Caforio A, et al.
Dilated cardiomyopathy. Nature Reviews
Disease Primers. 2019; 32 (5): 1 - 19.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third
universal definition of myocardial infarction.
European heart journal. 2012; 33 (20): 2551-
67.
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML,
Chaitman BR, White HD. Prognostic outcome
of routine clinical noninvasive multidetector-
row computed tomography coronary
angiography in patients with suspected
coronary artery disease: a 2-year follow-up 
study. La radiologia medica. 2011; 116 (4): 
521-31. 
4. Thygesen K, Alpert JS, White HD. Joint
ESC/ACCF/AHA/WHF Task Force for the
Redefinition of Myocardial Infarction. G Ital
Cardiol (rome). 2008; 9: 209-22.
5. Steg PG, James SK, Atar D, et al. Task Force on
the management of ST-segment elevation
acute myocardial infarction of the European
Society of Cardiology (ESC). ESC Guidelines for
the management of acute myocardial
infarction in patients presenting with ST-
segment elevation. Eur Heart J. 2012; 33 (20):
2569-619.
6. Triposkiadis F, Moyssakis I, Hadjinikolaou L, et
al. Left atrial systolic function is depressed in
idiopathic and preserved in ischemic dilated
cardiomyopathy. European journal of clinical
investigation. 1999; 29: 905-12.
7. Ito T, Suwa M, Hirota Y, Otake Y, Moriguchi A,
Kawamura K. Influence of left atrial function
on Doppler transmitral and pulmonary venous
flow patterns in dilated and hypertrophic
cardiomyopathy: evaluation of left atrial
appendage function by transesophageal
echocardiography. American heart journal.
1996; 131 (1): 122-30.
8. Triposkiadis F, Pitsavos C, Boudoulas H, Trikas
A, Toutouzas P. Left atrial myopathy in
idiopathic dilated cardiomyopathy. American
heart journal. 1994; 128 (2): 308-15.
9. Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori
M, Kamada T. High prevalence of atrial fibrosis
in patients with dilated cardiomyopathy.
Journal of the American College of Cardiology.
1995; 25 (5): 1162-9.
10. Paraskevaidis IA, Dodouras T, Adamopoulos S,
Kremastinos DT. Left atrial functional reserve
in patients with nonischemic dilated
cardiomyopathy: an echocardiographic
dobutamine study. Chest. 2002; 122 (4): 1340-
7.
11. Moyssakis I, Papadopoulos D, Kelepeshis G,
Gialafos E, Votteas V, Triposkiadis F. Left atrial
systolic reserve in idiopathic vs. ischaemic‐
dilated cardiomyopathy. European journal of
clinical investigation. 2005; 35 (6): 355-61.
12. Urheim S, Edvardsen T, Torp H, Angelsen B,
Smiseth OA. Myocardial strain by Doppler
34 Zahrah A 
echocardiography: validation of a new method 
to quantify regional myocardial function. 
Circulation. 2000; 102 (10): 1158-64. 
13. Støylen A, Heimdal A, Bjørnstad K, et al. Strain
rate imaging by ultrasonography in the
diagnosis of coronary artery disease. Journal of
the American Society of Echocardiography.
2000; 13 (12): 1053-64.
14. Bohs LN, Trahey GE. A novel method for angle
independent ultrasonic imaging of blood flow
and tissue motion. IEEE Transactions on
Biomedical Engineering. 1991; 38 (3): 280-6.
15. Amundsen BH, Helle-Valle T, Edvardsen T, et
al. Noninvasive myocardial strain 
measurement by speckle tracking 
echocardiography: validation against 
sonomicrometry and tagged magnetic
resonance imaging. J Am Coll Cardiol. 2006; 47
(4): 789-93.
16. Notomi Y, Shiota T, Popović ZB, et al.
Measurement of ventricular torsion by two-
dimensional ultrasound speckle tracking
imaging. Journal of the American College of
Cardiology. 2005;45(12):2034-41.
17. Wakami K, Ohte N, Asada K, et al. Correlation
between left ventricular end-diastolic pressure
and peak left atrial wall strain during left
ventricular systole. Journal of the American
Society of Echocardiography. 2009; 22 (7):
847-51.
18. Waldman LK, Fung Y, Covell JW. Transmural
myocardial deformation in the canine left
ventricle. Normal in vivo three-dimensional
finite strains. Circulation research. 1985; 57
(1): 152-63.
19. Inaba Y, Yuda S, Kobayashi N, et al. Strain rate
imaging for noninvasive functional 
quantification of the left atrium: comparative 
studies in controls and patients with atrial 
fibrillation. Journal of the American Society of 
Echocardiography. 2005;18(7):729-36. 
20. Guler A, Tigen K, Dundar C, et al. Left atrial
deformation and nonischemic dilated
cardiomyopathy. Herz. 2014; 39 (2): 251-7.
21. D'Andrea A, Caso P, Romano S, et al.
Association between left atrial myocardial
function and exercise capacity in patients with
either idiopathic or ischemic dilated
cardiomyopathy: a two-dimensional speckle
strain study. International journal of
cardiology. 2009; 132 (3): 354-63.
22. Barbosa MM, Rocha MOC, Botoni FA, Ribeiro
ALP, Nunes MCP. Is atrial function in Chagas
dilated cardiomyopathy more impaired than in
idiopathic dilated cardiomyopathy? European
Journal of Echocardiography. 2011; 12 (9):
643-7.
23. Sen L, Cui G, Fonarow GC, Laks H. Differences
in mechanisms of SR dysfunction in ischemic
vs. idiopathic dilated cardiomyopathy.
American journal of physiology Heart and
circulatory physiology. 2000; 279 (2): H709-18.
24. Molina-Navarro MM, Trivino JC, Martinez-Dolz
L, et al. Functional networks of
nucleocytoplasmic transport-related genes
differentiate ischemic and dilated
cardiomyopathies. A new therapeutic
opportunity. PloS one. 2014; 9 (8): e104709.
25. Barbier P, Solomon SB, Schiller NB, Glantz SA.
Left atrial relaxation and left ventricular
systolic function determine left atrial reservoir
function. Circulation. 1999; 100 (4): 427-36.
